<DOC>
	<DOCNO>NCT00004410</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine whether infant treat tauroursodeoxycholic acid ( TUDCA ) low peak direct bilirubin , ALT , AST , glutamyltranspeptidase level reduce duration cholestasis compare nontreatment arm . II . Determine significance lower birth weight longer duration total parenteral nutrition ( TPN ) increase risk TPN associate cholestasis increase benefit TUDCA therapy . III . Determine whether TUDCA therapy lead significant reduction appearance biliary tract sludge and/or stone formation infant . IV . Determine whether TUDCA therapy lead reduce urinary excretion potentially hepatotoxic bile acid compare untreated arm match birth weight duration TPN .</brief_summary>
	<brief_title>Randomized Study Tauroursodeoxycholic Acid Prophylactic Therapy Total Parenteral Nutrition Associated Cholestasis Infants</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize study . Patients stratify birth weight . Patients randomized pair birth weight receive either placebo arm I tauroursodeoxycholic acid ( TUDCA ) arm II . TUDCA administer mouth , nasogastric tube , gastrostomy tube twice daily . After 2 week therapy , bile sample obtain via duodenal tube . An ultrasound examination liver biliary tract perform 2 week every 3 week thereafter discontinuation therapy presence biliary tract sludge note 2 consecutive examination . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Tauroursodeoxycholic acid</mesh_term>
	<mesh_term>Taurochenodeoxycholic Acid</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Hospitalized infant anticipate require total parenteral nutrition great 2 week : Major gastrointestinal anomaly ( gastroschisis , rupture omphalocele ) OR Resection ( necrotizing enterocolitis , volvulus ) No evidence biliary tract abnormalities No evidence form cholestatic liver disease Patient Characteristics Renal : No life threaten renal disease Cardiovascular : No life threaten cardiovascular disease Other : No multiple congenital abnormality</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Days</maximum_age>
	<verification_date>August 1998</verification_date>
	<keyword>cholestasis</keyword>
	<keyword>gastrointestinal disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>